Although mesenchymal stromal cells (MSCs) from primary tissues have been successfully applied in the clinic, their expansion capabilities are limited and results are variable. MSCs derived from... Show moreAlthough mesenchymal stromal cells (MSCs) from primary tissues have been successfully applied in the clinic, their expansion capabilities are limited and results are variable. MSCs derived from human-induced pluripotent stem cells (hiMSCs) are expected to overcome these limitations and serve as a reproducible and sustainable cell source. We have explored characteristics and therapeutic potential of hiMSCs in comparison to hBMSCs. RNA sequencing confirmed high resemblance, with average Pearson correlation of 0.88 and Jaccard similarity index of 0.99, and similar to hBMSCs the hiMSCs released extracellular vesicles with in vitro immunomodulatory properties. Potency assay with TNF alpha and IFN gamma demonstrated an increase in well-known immunomodulatory genes such as IDO1, CXCL8/IL8, and HLA-DRA which was also highlighted by enhanced secretion in the media. Notably, expression of 125 genes increased more than 1000-fold. These genes were predicted to be regulated by NFKB signaling, known to play a central role in immune response. Altogether, our data qualify hiMSCs as a promising source for cell therapy and/or cell-based therapeutic products. Additionally, the herewith generated database will add to our understanding of the mode of action of regenerative cell-based therapies and could be used to identify relevant potency markers. Show less
Extracellular vesicles (EVs) are promising drug carriers of photosensitizers for photodynamic therapy (PDT) in cancer treatment, due to their ability to circulate in blood and enter cells... Show moreExtracellular vesicles (EVs) are promising drug carriers of photosensitizers for photodynamic therapy (PDT) in cancer treatment, due to their ability to circulate in blood and enter cells efficiently. The therapeutic potential of EVs has been suggested to depend on the type and physiological state of their cell of origin. However, the effects of deriving EVs from various cells in different physiological states on their antitumor capacity are rarely evaluated. In the present study, we compared the antitumor efficacy of EV-mediated PDT by incorporating the photosensitizer Zinc Phthalocyanine (ZnPc) into EVs from multiple cells sources. ZnPc was incorporated by a direct incubation strategy into EVs derived from immune cells (M1-like macrophages and M2-like macrophages), cancer cells (B16F10 melanoma cancer cells) and external sources (milk). Our data show that all EVs are suitable carriers for ZnPc and enable efficient PDT in vitro in co-culture models and in vivo. We observed that EV-mediated PDT initiates immunogenic cell death through the release and exposure of damage associated molecular patterns (DAMPs) on cancer cells, which subsequently induced dendritic cell (DC) maturation. Importantly, of all ZnPc-EVs tested, in absence of light only M1-ZnPc displayed toxicity to MC38, but not to DC, in monoculture and in co-culture, indicating specificity for cancer over immune cells. In MC38 tumor-bearing mice, only M1-ZnPc induced a tumor growth delay compared to control in absence of light. Interestingly, M1- but not M2-mediated PDT, induced complete responses against MC38 tumors in murine models (100% versus 38% of cases, respectively), with survival of all animals up to at least 60 days post inoculation. Finally, we show that all cured animals are protected from a rechallenge with MC38 cells, suggesting the induction of immunological memory after EV-mediated PDT. Together, our data show the importance of the cell type from which the EVs are obtained and highlight the impact of the immunological state of these cells on the antitumor efficacy of EV-mediated PDT. Show less
The glioma microenvironment harbors a variety of immune cells including innate immune cells such as monocytes, macrophages and microglia. Microglia are the major innate immune cells present in the... Show moreThe glioma microenvironment harbors a variety of immune cells including innate immune cells such as monocytes, macrophages and microglia. Microglia are the major innate immune cells present in the glioma microenvironment. Communication between glioma and these immune cells is crucial to maintain a tumor-promoting environment. In this thesis the role of a specific type of communication is described. In detail, the consequence of extracellular communication from glioma to the innate immune cells is studied, this includes the transferring of messages (including miRNAs) through extracellular vesicles. In addition, the changes that these cells undergo in the presence of a tumor is documented. Show less
This thesis describes the potential use of these cardiac progenitor-derived extracellular vesicles (EVs) for cardiac repair and focused on translational aspects that could accelerate clinical... Show moreThis thesis describes the potential use of these cardiac progenitor-derived extracellular vesicles (EVs) for cardiac repair and focused on translational aspects that could accelerate clinical implementation of EV-based therapeutics. The first steps have been made in optimizing EV production processes such as EV isolation and storage. Furthermore, this thesis described a potential method for sustained EV release and to prolong therapeutic exposure by using a hydrogel. Ultimately, this could contribute to improved efficacy upon local delivery of EV therapeutics. Together, this thesis potentially contributes to fasten clinical adoption of EV-based therapeutics for patients with heart failure. Show less
Background Extracellular vesicles (EVs) have shown great potential for targeted therapy, as they have a natural ability to pass through biological barriers and, depending on their origin, can... Show moreBackground Extracellular vesicles (EVs) have shown great potential for targeted therapy, as they have a natural ability to pass through biological barriers and, depending on their origin, can preferentially accumulate at defined sites, including tumors. Analyzing the potential of EVs to target specific cells remains challenging, considering the unspecific binding of lipophilic tracers to other proteins, the limitations of fluorescence for deep tissue imaging and the effect of external labeling strategies on their natural tropism. In this work, we determined the cell-type specific tropism of B16F10-EVs towards cancer cell and metastatic tumors by using fluorescence analysis and quantitative gold labeling measurements. Surface functionalization of plasmonic gold nanoparticles was used to promote indirect labeling of EVs without affecting size distribution, polydispersity, surface charge, protein markers, cell uptake or in vivo biodistribution. Double-labeled EVs with gold and fluorescent dyes were injected into animals developing metastatic lung nodules and analyzed by fluorescence/computer tomography imaging, quantitative neutron activation analysis and gold-enhanced optical microscopy. Results We determined that B16F10 cells preferentially take up their own EVs, when compared with colon adenocarcinoma, macrophage and kidney cell-derived EVs. In addition, we were able to detect the preferential accumulation of B16F10 EVs in small metastatic tumors located in lungs when compared with the rest of the organs, as well as their precise distribution between tumor vessels, alveolus and tumor nodules by histological analysis. Finally, we observed that tumor EVs can be used as effective vectors to increase gold nanoparticle delivery towards metastatic nodules. Conclusions Our findings provide a valuable tool to study the distribution and interaction of EVs in mice and a novel strategy to improve the targeting of gold nanoparticles to cancer cells and metastatic nodules by using the natural properties of malignant EVs. Show less
Liu, S.; González, Prieto R.; Zhang, M.; Geurink, P.P.; Kooij, R.; Iyengar, P.V.; ... ; Dijke, P. ten 2019
Therapies directed to specific molecular targets are still unmet for triple-negative breast cancer (TNBC) patients. Deubiquitinases (DUBs) are emerging drug targets. The identification of a highly... Show moreTherapies directed to specific molecular targets are still unmet for triple-negative breast cancer (TNBC) patients. Deubiquitinases (DUBs) are emerging drug targets. The identification of a highly active DUBs in TNBC may lead to novel therapies.\n biochemical methods. A specific inhibitor was synthesised and its biochemical and biological functions were assessed in a range of assays. Finally, we used patient sera samples to investigate clinical correlations.\nTwo DUB activity profiling approaches identified UCHL1 as being highly active in TNBC cell lines and aggressive tumors. Functionally, UCHL1 promoted metastasis in zebrafish and murine breast cancer xenograft models. Mechanistically, UCHL1 facilitates TGFβ signaling-induced metastasis by protecting TGFβ type I receptor and SMAD2 from ubiquitination. We found that these responses are potently suppressed by the specific UCHL1 inhibitor, 6RK73. Furthermore, UCHL1 levels were significantly increased in TNBC patient sera, and highly enriched in sera exosomes as well as TNBC cell conditioned media. UCHL1 enriched exosomes stimulated breast cancer migration and extravasation, suggesting that UCHL1 may act in a paracrine manner to promote tumor progression.\nOur DUB activity profiling identified UCHL1 as a candidate oncoprotein that promotes TGFβ-induced breast cancer metastasis and may provide a potential target for TNBC treatment. Show less
Immune responsiveness is carefully regulated. Cells of the immune system have to respond adequately to invading micro-organisms and possibly to transformed cells, but tolerance for the own body... Show moreImmune responsiveness is carefully regulated. Cells of the immune system have to respond adequately to invading micro-organisms and possibly to transformed cells, but tolerance for the own body constituents needs to be preserved. Dendritic cells (DC) comprise a family of professional antigen presenting cells (APC) that play a central role in the regulation of the immune response. Immature DC, located in the periphery, can efficiently take up Ag, but lack the co-stimulatory signals for effective T-cell activation. Upon maturation, DC migrate to secondary lymphoid organs and increase the expression of co-stimulatory molecules and MHC molecules. Mature DC are very efficient in priming na____ve T-cells. In contrast to their T-cell priming capacity, DC in peripheral tissues constitutively process and present Ag in the absence of pathogen-related or endogenous inflammatory stimuli, and make a major contribution to peripheral tolerance by inducing unresponsiveness or deletion of specific T-cells. The central role of DC in controlling immunity makes these cells attractive tools for many clinical situations that involve T-cells: induction of tolerance in case of transplantation, allergy and autoimmune disease and induction of efficient T-cell responsiveness in case of infection and tumors. Many tumor components do not elicit Ag-specific T-cell responses in patients, which may be due to the absence of functional DC in tumors or the secretion of factors by tumor cells that reduce DC development and function. Application of tumor Ag to DC ex vivo and reinfusion of these DC leads to induction of specific immunity. In animals this strategy can lead to protection against tumors and even a reduction in size of established tumors. At present similar studies are carried out in patients. The research described in this thesis focuses on the requirements for induction of efficient cytotoxic T lymphocyte (CTL)- responses and tumor immunity by DC. Different modes of Ag presentation were studied for the induction of CTL-responses and tumor protection. Show less